{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:29:10Z","timestamp":1786739350572,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>There is high prevalence of non-alcoholic fatty liver disease in individuals with type 2 diabetes mellitus (T2D), and available evidence suggests higher prevalence of NASH and advanced stages of fibrosis among T2D. Data regarding prevalence of clinically significant liver fibrosis (CSLF) in individuals with T2D is scarce. We investigated the prevalence of transient elastography (TE)-proven CSLF among patients of T2D attending a diabetes clinic at a tertiary care center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A cross-sectional descriptive evaluation study of 603 consecutive adults with T2D was conducted to detect CSLF using TE. Steatosis was diagnosed using a controlled attenuation parameter &gt;237 dB\/m.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The prevalence of CSLF was 22.7%, and the prevalence of steatosis was 58.9% in our study. A higher body mass index (BMI) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), aspartate aminotransferase (AST;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), alanine aminotransferase (ALT;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), and low platelets (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001) were independent factors associated with CSLF. Elevated ALT and AST (\u226540 units\/L) levels were present in only 27.7% and 37.2% of individuals with CSLF, respectively. Twenty-six (4.31%) individuals had LSM &gt; 13.0 kPa.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>CSLF is highly prevalent in T2D patients attending a diabetes clinic at a tertiary care center, and the majority of such individuals have normal transaminase levels. Higher BMI, AST, and ALT values and lower platelet counts are associated with liver fibrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijem.ijem_203_23","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T02:04:09Z","timestamp":1718071449000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of Clinically Significant Liver Fibrosis as Measured by Transient Elastography due to Non-alcoholic Fatty Liver Disease in Indian individuals with Type 2 Diabetes Mellitus"],"prefix":"10.4103","author":[{"given":"Rajat","family":"Deb","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumik","family":"Goswami","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjan","family":"Sengupta","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Baidya","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhu Ranjan","family":"Khare","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joydip","family":"Datta","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Jhaveri","sequence":"additional","affiliation":[{"name":"Medical Affairs, Zydus Lifesciences Limited, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousumi","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debes","family":"Ray","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MED.0b013e3283293015","article-title":"Nonalcoholic fatty liver disease in type 2 diabetes mellitus","volume":"16","author":"Cusi","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatol Baltim Md"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"European Association for the Study of the Liver (EASL);European Association for the Study of Diabetes (EASD);EuropeanAssociation for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cgh.2007.07.020","article-title":"Ultrasound- based transient elastography for the detection of hepatic fibrosis: Systematic review and meta-analysis","volume":"5","author":"Talwalkar","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrgastro.2016.86","article-title":"Critical comparison of elastography methods to assess chronic liver disease","volume":"13","author":"Friedrich-Rust","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.27981","article-title":"Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study","volume":"63","author":"Koehler","year":"2016","journal-title":"Hepatology"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc06-1539","article-title":"Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease","volume":"30","author":"Tolman","year":"2007","journal-title":"Diabetes Care"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc13-2704","article-title":"Nonalcoholic Fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes","volume":"37","author":"Targher","year":"2014","journal-title":"Diabetes Care"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: Causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jgh3.12606","article-title":"Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes","volume":"5","author":"Kuchay","year":"2021","journal-title":"JGH Open"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"R17-20240828","first-page":"S19","article-title":"Gender differences in nonalcoholic fatty liver disease","volume":"12","author":"Nagral","year":"2022","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jhep.2000.16602","article-title":"Practices of liver biopsy in France: Results of a prospective nationwide survey. For the group of epidemiology of the french association for the study of the liver (AFEF)","volume":"32","author":"Cadranel","year":"2000","journal-title":"Hepatology"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/hep.510300624","article-title":"Pain experienced during percutaneous liver biopsy","volume":"30","author":"Castera","year":"1999","journal-title":"Hepatology"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.20535","article-title":"Sources of variability in histological scoring of chronic viral hepatitis","volume":"41","author":"Rousselet","year":"2005","journal-title":"Hepatology"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/jhep.2003.50223","article-title":"Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?","volume":"37","author":"Afdhal","year":"2003","journal-title":"Hepatology"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_203_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:28:15Z","timestamp":1786735695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_203_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":25,"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_203_23","relation":{},"ISSN":["2230-9500","2230-8210"],"issn-type":[{"value":"2230-9500","type":"print"},{"value":"2230-8210","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"2023-05-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}